Article Menu
- Academic Editors
- Subscribe SciFeed
- Recommended Articles
- Related Info Links
-
More by Authors Links
- on DOAJ
- Bagnasco, D.
- Nicola, S.
- Testino, E.
- Brussino, L.
- Pini, L.
- Caminati, M.
- Piccardo, F.
- Canevari, R. Frank
- Melissari, L.
- Ioppi, A.
- Guastini, L.
- Lombardi, C.
- Milanese, M.
- Losa, F.
- Robbiano, M.
- De Ferrari, L.
- Riccio, A. Maria
- Guida, G.
- Bonavia, M.
- Fini, D.
- Balbi, F.
- Caruso, C.
- Paggiaro, P.
- Blasi, F.
- Heffler, E.
- Paoletti, G.
- Canonica, G. Walter
- Senna, G.
- Passalacqua, G.
- on behalf of SANI, .
- on Google Scholar
- Bagnasco, D.
- Nicola, S.
- Testino, E.
- Brussino, L.
- Pini, L.
- Caminati, M.
- Piccardo, F.
- Canevari, R. Frank
- Melissari, L.
- Ioppi, A.
- Guastini, L.
- Lombardi, C.
- Milanese, M.
- Losa, F.
- Robbiano, M.
- De Ferrari, L.
- Riccio, A. Maria
- Guida, G.
- Bonavia, M.
- Fini, D.
- Balbi, F.
- Caruso, C.
- Paggiaro, P.
- Blasi, F.
- Heffler, E.
- Paoletti, G.
- Canonica, G. Walter
- Senna, G.
- Passalacqua, G.
- on behalf of SANI, .
- on PubMed
- Bagnasco, D.
- Nicola, S.
- Testino, E.
- Brussino, L.
- Pini, L.
- Caminati, M.
- Piccardo, F.
- Canevari, R. Frank
- Melissari, L.
- Ioppi, A.
- Guastini, L.
- Lombardi, C.
- Milanese, M.
- Losa, F.
- Robbiano, M.
- De Ferrari, L.
- Riccio, A. Maria
- Guida, G.
- Bonavia, M.
- Fini, D.
- Balbi, F.
- Caruso, C.
- Paggiaro, P.
- Blasi, F.
- Heffler, E.
- Paoletti, G.
- Canonica, G. Walter
- Senna, G.
- Passalacqua, G.
- on behalf of SANI, .
Need Help?
Order Article Reprints
Journal: Biomedicines, 2023
Volume: 11
Number: 2424
2424
Article:
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders
Authors:
by
Diego Bagnasco, Stefania Nicola, Elisa Testino, Luisa Brussino, Laura Pini, Marco Caminati, Federica Piccardo, Rikki Frank Canevari, Laura Melissari, Alessandro Ioppi, Luca Guastini, Carlo Lombardi, Manlio Milanese, Francesca Losa, Michela Robbiano, Laura De Ferrari, Anna Maria Riccio, Giuseppe Guida, Marco Bonavia, Donatella Fini, Francesco Balbi, Cristiano Caruso, Pierluigi Paggiaro, Francesco Blasi, Enrico Heffler, Giovanni Paoletti, Giorgio Walter Canonica, Gianenrico Senna, Giovanni Passalacqua and on behalf of SANIadd
Show full author list
remove
Hide full author list
Link:
https://www.mdpi.com/2227-9059/11/9/2424
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.
Cite
Bagnasco, D.; Nicola, S.; Testino, E.; Brussino, L.; Pini, L.; Caminati, M.; Piccardo, F.; Canevari, R.F.; Melissari, L.; Ioppi, A.; et al. Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders. Biomedicines 2023, 11, 2424. https://doi.org/10.3390/biomedicines11092424
Bagnasco D, Nicola S, Testino E, Brussino L, Pini L, Caminati M, Piccardo F, Canevari RF, Melissari L, Ioppi A, et al. Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders. Biomedicines. 2023; 11(9):2424. https://doi.org/10.3390/biomedicines11092424
Chicago/Turabian StyleBagnasco, Diego, Stefania Nicola, Elisa Testino, Luisa Brussino, Laura Pini, Marco Caminati, Federica Piccardo, Rikki Frank Canevari, Laura Melissari, Alessandro Ioppi, and et al. 2023. "Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders" Biomedicines 11, no. 9: 2424. https://doi.org/10.3390/biomedicines11092424
APA StyleBagnasco, D., Nicola, S., Testino, E., Brussino, L., Pini, L., Caminati, M., Piccardo, F., Canevari, R. F., Melissari, L., Ioppi, A., Guastini, L., Lombardi, C., Milanese, M., Losa, F., Robbiano, M., De Ferrari, L., Riccio, A. M., Guida, G., Bonavia, M., ... on behalf of SANI. (2023). Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders. Biomedicines, 11(9), 2424. https://doi.org/10.3390/biomedicines11092424
